Codiak BioSciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Codiak BioSciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 687% to $22,935,000. The net income raised on -$41,633,000 and profit margin reached -182%. Total operating expenses were $92,484,000.
Profit Margin
| 2018 | 0 | -44.54M | |
|---|---|---|---|
| 2019 | 388K | -79.25M | -20425.77% |
| 2020 | 2.91M | -88.93M | -3050.81% |
| 2021 | 22.93M | -41.63M | -181.53% |
CDAK Income Statement (2018 – 2021)
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 22.93M | 2.91M | 388K | 0 |
Cost of revenue | 0 | 0 | 0 | 0 |
Gross profit | 22.93M | 2.91M | 388K | 0 |
Operating exp. | ||||
Research and development | 64.85M | 73.98M | 59.50M | 36.54M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 92.48M | 93.83M | 80.54M | 46.44M |
Operating income | -69.54M | -90.91M | -80.15M | -46.44M |
Other income (expenses), net | 32.39M | -747K | 2.19M | 1.89M |
Income before tax | -37.15M | -91.66M | -77.96M | -44.54M |
Income tax expense | 4.47M | -2.73M | 1.29M | 1.89M |
Net income | -41.63M | -88.93M | -79.25M | -44.54M |
Earnings per share | ||||
Basic EPS | -1.91 | -14.04 | -6.03 | -3.4 |
Diluted EPS | -1.91 | -14.04 | -6.03 | -3.4 |
| Data source | Data source |